TESORO GOLD LTD — Capital/Financing Update 2014

Sep 16, 2014

Continuation Investments Limited

17 September 2014

CAPITAL STRUCTURE

Market Announcements Office Australian Securities Exchange, Sydney

By E-Lodgement

Transaction Update

Continuation Investments Limited (ASX:COT) advises that work is continuing on the acquisition of leading-edge Colorado based medical technology and device company The Biofusionary Corporation Limited ( TBC ) as announced to the market on 29 July 2014 ( Transaction ).

Shares: 19.86m Options: 2.25m Cash: $1.48m (June 2014)

BOARD & MANAGEMENT

Mr Jeremy King Chairman

Mr Andrew Worland Non-Executive Director

There has been a delay to the entry into stock transfer documents with each of the shareholders of TBC and to the Transaction timetable, due mainly to TBC obtaining detailed US regulatory and tax advice. Such advice is expected to be received soon – following from that advice, it may be that certain aspects of the Transaction require restructuring in order to achieve a satisfactory outcome to all parties.

Mr David Church Non-Executive Director

Ms Sarah Smith Company Secretary

The Company shall keep investors and shareholders informed of developments.

For and on Behalf of the Board

==> picture [86 x 50] intentionally omitted <==

Jeremy King Chairman

REGISTERED OFFICE 945 Wellington Street West Perth WA 6005

CONTACT DETAILS Tel: +61 8 9322 7600 Fax: +61 8 9322 7602

SHARE REGISTRY Automic Registry Services 7 Ventnor Avenue West Perth WA 6005

ASX CODE COT